Grant: Discovery Grants Program - Individual
University of Alberta
$36,000.00
Affinity selection, characterization and sequencing of high-affinity immunoglobulins
FY 2024-25
Summary
Immunoglobulins, the key molecules of the immune response, represent one of the most diverse and complex classes of proteins due to their hypervariable regions, post-translational modifications, and numerous allotypes, subclasses, and isotypes. Immunoglobulins remain exceptional tools for affinity analysis of proteins and highly promising and specific therapeutic agents. Characterization of sequence and modifications of therapeutic antibodies by mass spectrometry is a rapidly growing field. While standard separation approaches, mass spectrometry methods, and bioinformatic tools enable de novo sequencing of the purified recombinant monoclonal antibodies, informative sequencing of polyclonal mixtures is a formidable challenge that requires development of the next-generation techniques and assays.
My long-term research program is aimed at developing novel analytical techniques and assays for the affinity selection, characterization, and sequencing of immunoglobulins. I suggest that a combination of subclass-specific enrichments, tandem proteolytic cleavages, and epitope- and affinity-directed selections will enrich high-affinity immunoglobulin clones suitable for their characterization and sequencing by mass spectrometry. The proposed techniques and assays will enable testing a previously unexplored hypotheses: some pools of polyclonal antibodies may have low diversity and contain a small number of high-abundance, high-affinity clones which could be isolated and identified by mass spectrometry.
The specific 3-year Aims of our program include:
1) integration of an alternative protease ProAlanase into proteomic workflows;
2) development of targeted MS assays for ProAlanase-derived peptides;
3) pairing of antibody heavy and light chains by native MS.
Our longer-term 5-year Aims include:
4) epitope- and affinity-directed selection of high-affinity clones from polyclonal antibody pools;
5) development of an integrated workflow for sequencing of high-affinity polyclonal antibodies.
The novelty of our program resides in the implementation of novel proteases (ProAlanase), novel analytical assays (targeted mass spectrometry for ProAlanase peptides), novel separation approaches, novel affinity ligands (anti-CDR3), and integration of recent knowledge of structure, affinity, and sequence diversity of monoclonal and polyclonal antibodies. The proposed workflow for affinity selection, characterization, and sequencing of high-affinity immunoglobulins will advance the discovery of monoclonal antibodies, development of affinity reagents and novel diagnostics, and basic immunology studies. Our research program will train a new generation of HQP with comprehensive expertise in analytical chemistry, mass spectrometry, proteomics, and antibody sequencing.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05909
Name nom
Drabovich, Andrei
Department département
Laboratory Medicine and Pathology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Affinity selection, characterization and sequencing of high-affinity immunoglobulins
Keywords
mass spectrometry; antibody sequencing; affinity separations; immunoglobulins; proteases; immunoglobulin class switching; targeted proteomics; affinity interactions
Application summary
Immunoglobulins, the key molecules of the immune response, represent one of the most diverse and complex classes of proteins due to their hypervariable regions, post-translational modifications, and numerous allotypes, subclasses, and isotypes. Immunoglobulins remain exceptional tools for affinity analysis of proteins and highly promising and specific therapeutic agents. Characterization of sequence and modifications of therapeutic antibodies by mass spectrometry is a rapidly growing field. While standard separation approaches, mass spectrometry methods, and bioinformatic tools enable de novo sequencing of the purified recombinant monoclonal antibodies, informative sequencing of polyclonal mixtures is a formidable challenge that requires development of the next-generation techniques and assays.
My long-term research program is aimed at developing novel analytical techniques and assays for the affinity selection, characterization, and sequencing of immunoglobulins. I suggest that a combination of subclass-specific enrichments, tandem proteolytic cleavages, and epitope- and affinity-directed selections will enrich high-affinity immunoglobulin clones suitable for their characterization and sequencing by mass spectrometry. The proposed techniques and assays will enable testing a previously unexplored hypotheses: some pools of polyclonal antibodies may have low diversity and contain a small number of high-abundance, high-affinity clones which could be isolated and identified by mass spectrometry.
The specific 3-year Aims of our program include:
1) integration of an alternative protease ProAlanase into proteomic workflows;
2) development of targeted MS assays for ProAlanase-derived peptides;
3) pairing of antibody heavy and light chains by native MS.
Our longer-term 5-year Aims include:
4) epitope- and affinity-directed selection of high-affinity clones from polyclonal antibody pools;
5) development of an integrated workflow for sequencing of high-affinity polyclonal antibodies.
The novelty of our program resides in the implementation of novel proteases (ProAlanase), novel analytical assays (targeted mass spectrometry for ProAlanase peptides), novel separation approaches, novel affinity ligands (anti-CDR3), and integration of recent knowledge of structure, affinity, and sequence diversity of monoclonal and polyclonal antibodies. The proposed workflow for affinity selection, characterization, and sequencing of high-affinity immunoglobulins will advance the discovery of monoclonal antibodies, development of affinity reagents and novel diagnostics, and basic immunology studies. Our research program will train a new generation of HQP with comprehensive expertise in analytical chemistry, mass spectrometry, proteomics, and antibody sequencing.